E. Burak

发表

AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 1): pharmacokinetics.

M. Struys, A. Vanluchene, L. V. Van Bortel, 2005, Anesthesiology.

Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor.

Qun Liu, T. Tsukamoto, B. Slusher, 2003, Journal of medicinal chemistry.

Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rats

J. Fechner, H. Schwilden, M. Schywalsky, 2003, European journal of anaesthesiology.

In vivo inhibition of phenacetin oxidation by suicide substrate 1-aminobenzotriazole.

B. Mico, J. Swagzdis, D. Federowicz, 1987, Drug metabolism and disposition: the biological fate of chemicals.

The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693.

D. Hilt, J. Gerven, E. Bortey, 2005, British journal of clinical pharmacology.

IGF-1R Targeted Alpha Therapeutic FPI-1434 causes DNA Double-stranded Breaks and Induces Regression in Preclinical Models of Human Cancer

J. Valliant, N. Grinshtein, Meiduo Hu, 2019, Journal of Medical Imaging and Radiation Sciences.

Pharmacokinetics and clinical pharmacodynamics of the new propofol prodrug GPI 15715 in volunteers.

J. Fechner, H. Schwilden, J. Schüttler, 2003, Anesthesiology.

Objectives of Biomarkers in Early Drug Development Biomarkers for Pharmacological Effects Biomarkers for (patho)physiological Principle Biomarkers for Therapeutic Principle Table 1 Number of Tests within Individual Domains Neuropsychological Domains Neuroleptics Selective Serotonin Re-uptake Inhibit

M. Ferrari, F. Zitman, D. Hilt, 2022 .

Delafloxacin Population Pharmacokinetics and Covariate Exploration

S. Bhavnani, P. Ambrose, A. Forrest, 2010 .

A phase I study of [225Ac]-FPI-1434 radioimmunotherapy in patients with IGF-1R expressing solid tumors.

F. Saad, J. Valliant, R. Juergens, 2019, Journal of Clinical Oncology.

Suppression of in vivo clearance of N-nitrosodimethylamine in mice by cotreatment with ethanol.

L. Anderson, P. Magee, J. Carter, 1994, Drug metabolism and disposition: the biological fate of chemicals.

Pharmacokinetic/-dynamic modelling of the new propofol prodrug GPI-15715 in rats

H. Schwilden, M. Schywalsky, J. Vornov, 2002 .

Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacokinetics and characterization of glucuronide metabolites.

L. Anderson, S. Hecht, J. Rice, 1993, Carcinogenesis.